Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q2 2025 (June 30)8holders
1new positions
1sold out
$2.28avg. 13F price*
At the end of Q2 2025, 8 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Nomura Holdings Inc. ($1.1M), Bank of New York Mellon Corp ($261K) and Sei Investments Co. ($120K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32K |
| Exits | 1 | $14K |
All 13F filers, Q1 2025 → Q2 2025: 37,000 shares bought and 35,000 shares sold, net +2,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Nomura Holdings Inc. | 0.01% | No change | 48,880 | $1.1M |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $261K |
| Sei Investments Co. | 0.00% | Reduce -11.5% | 139,000 | $120K |
| Cetera Investment Advisers | 0.00% | No change | 120,000 | $104K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -1.2% | 82,000 | $71K |
| Choreo, LLC | 0.00% | New | 37,000 | $32K |
| Stephens Inc. | 0.00% | No change | 26,000 | $22K |
| Comerica Bank | 0.00% | No change | 11,000 | $9K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.